In December 2016, American agricultural biotechnology corporation Mosanto announced that they’ve approved the Merger of Mosanto with German pharmaceutical company Bayer Aktiengesellschaft which is expected to cost $66 billion. The purpose of the merger according to Werner Bauman, CEO of Bayer AG, is offer new Read More ...

The post Mosanto-Bayer Merger appeared first on G-PRINCE WORLD.